2026-01-22 - Analysis Report
**Company Overview**
BlackRock is a multinational investment management corporation based in the United States.

**Return Rate Comparison**

* Cumulative return of review stock (BLK): 56.75%
* Cumulative return of comparison stock (S&P 500, VOO): 91.55%
* Divergence: -31.70 (absolute)
* Relative divergence: 19.50% (indicating the current position when the minimum-maximum fluctuation range is set to 100)

The review stock (BLK) has lower cumulative returns compared to the comparison stock (VOO) with a larger divergence of -31.70. This suggests a possible lower investment potential for BLK in the long term.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -4.0% | 23.3% | -9.0% | 1.4  | 61.0B  |
| 2017-2019  | 14.0% | 23.3% | -4.0% | 1.3  | 78.0B  |
| 2018-2020  | -2.0% | 23.3% | -23.0% | 1.2  | 112.0B |
| 2019-2021  | 63.0% | 15.5% | 20.0%  | 1.2  | 142.1B |
| 2020-2022  | -2.0% | 39.1% | 0.0%   | 1.2  | 109.9B |
| 2021-2023  | 6.0%  | 39.1% | 5.0%   | 1.3  | 126.0B |
| 2022-2024  | 23.0% | 30.2% | 4.0%   | 1.2  | 159.1B |
| 2023-2025  | 21.0% | 24.7% | -41.0% | 1.1  | 166.1B |

The review stock (BLK) has varying returns across different years but generally exhibits an average beta of 1.27, indicating a moderate correlation to market movements.

**Recent Stock Price Fluctuations**

* Close: $1127.85
* Last-market: $1127.85 (price), $1110.05 (previous close), 1.6% (change)
* 5-day SMA: $1129.91
* 20-day SMA: $1099.37
* 60-day SMA: $1077.65

The recent stock price has shown a moderate increase with a 5-day SMA slightly above the current price. However, the 20-day SMA and 60-day SMA are below the current price.

**RSI, PPO Index, and Delta Divergence**

* Market Risk Indicator (MRI): 0.80 (medium risk)
* RSI: 58.20 (neutral)
* PPO: 0.36 (buy signal)
* Recent (20 days) relative divergence change: 15.00 (+) (improving)
* 7-day Rank change: 56 (+) (rank up)
* 7-day Dynamic Expected Return change: 115.60 (+) (improving)
* Expected Return (%): -33.10% (expected excess return compared to S&P 500 if invested long-term)

The review stock (BLK) exhibits a medium risk profile with a neutral RSI and a buy signal from PPO. The recent relative divergence change is improving, and the 7-day rank change and dynamic expected return change also indicate an improvement.

**Recent News and Significant Events**

See the provided headlines.

1.  PAX vs. BLK: Which Stock Is the Better Value Option? - Yahoo! Finance Canada (news.google.com)
2.  BlackRock Surges On Q4 Beat, Dividend Hike. Shares In Bullish Pattern. - Investor's Business Daily (news.google.com)
3.  Vest Financial LLC Trims Stock Holdings in BlackRock $BLK - MarketBeat (news.google.com)
4.  BlackRock: Q4 Shows This Giant's Growth Is Far From Over (NYSE:BLK) - Seeking Alpha (news.google.com)
5.  BlackRock Influence Grows As Rieder Fed Talk Meets New Growth Engines - simplywall.st (news.google.com)
6.  BlackRock stock set for cautious open after BLK slides 4.6% on tariff shock - TechStockÂ² (news.google.com)

The recent news and events suggest varying sentiments towards the review stock (BLK), from a bullish pattern to a cautious opening.

**Analyst Opinions**

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.82 (~Buy)
  - Opinions: 15
  - Target Price (avg/high/low): 1324.40 / 1550.00 / 1170.00

The analyst consensus is slightly bullish, with a mean of 1.82 (~Buy) and opinions from 15 analysts. The target price range varies from 1170.00 to 1550.00.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|------|---------|
| 2024-08-06 | 10.07 | 4.80 B$ |
| 2024-05-07 | 10.58 | 4.73 B$ |
| 2023-11-06 | 10.75 | 4.52 B$ |
| 2023-08-04 | 9.13 | 4.46 B$ |
| 2024-08-06 | 9.13 | 4.46 B$ |

The review stock (BLK) has shown increasing earnings per share (EPS) with average revenue above $4.5 billion. The EPS variation between 2023 and 2024 may require further explanation.

**Financial Information: Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $6.51B | 45.94% |
| 2025-06-30 | $5.42B | 47.87% |
| 2025-03-31 | $5.28B | 47.88% |
| 2024-12-31 | $5.68B | 49.25% |

The review stock (BLK) has shown moderate revenue growth and profit margins ranging from 45.94% to 49.25%.

**Financial Information: Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $55.52B | 2.38% |
| 2025-06-30 | $49.14B | 3.24% |
| 2025-03-31 | $48.04B | 3.14% |
| 2024-12-31 | $47.49B | 3.52% |

The review stock (BLK) has maintained equity of around $45 billion and exhibited a stable return on equity (ROE) ranging from 2.38% to 3.52%.

**Comprehensive Analysis (Summary of previous items)**

The review stock (BLK) has shown varying returns across different years with a moderate beta of 1.27. The recent stock price has increased, with the 5-day SMA slightly above the current price. The MRI indicates a medium risk profile, and the RSI is neutral. The PPO signal is buy, and the recent relative divergence change is improving. The review stock (BLK) exhibits increasing earnings per share (EPS) and average revenue above $4.5 billion with moderate profit margins ranging from 45.94% to 49.25%. The equity has remained around $45 billion, and the return on equity (ROE) has been stable with a range of 2.38% to 3.52%.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.